Literature DB >> 25700366

Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer.

Chad Walesky1, Udayan Apte.   

Abstract

Hepatocyte nuclear factor 4α (HNF4α) is an orphan nuclear receptor commonly known as the master regulator of hepatic differentiation, owing to the large number of hepatocyte-specific genes it regulates. Whereas the role of HNF4α in hepatocyte differentiation is well recognized and extensively studied, its role in regulation of cell proliferation is relatively less known. Recent studies have revealed that HNF4α inhibits proliferation not only of hepatocytes but also cells in colon and kidney. Further, a growing number of studies have demonstrated that inhibition or loss of HNF4α promotes tumorigenesis in the liver and colon, and reexpression of HNF4α results in decreased cancer growth. Studies using tissue-specific conditional knockout mice, knock-in studies, and combinatorial bioinformatics of RNA/ChIP-sequencing data indicate that the mechanisms of HNF4α-mediated inhibition of cell proliferation are multifold, involving epigenetic repression of promitogenic genes, significant cross talk with other cell cycle regulators including c-Myc and cyclin D1, and regulation of miRNAs. Furthermore, studies indicate that posttranslational modifications of HNF4α may change its activity and may be at the core of its dual role as a differentiation factor and repressor of proliferation. This review summarizes recent findings on the role of HNF4α in cell proliferation and highlights the newly understood function of this old receptor.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25700366      PMCID: PMC5841246          DOI: 10.3727/105221615X14181438356292

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  64 in total

Review 1.  Myc and the cell cycle.

Authors:  B Amati; K Alevizopoulos; J Vlach
Journal:  Front Biosci       Date:  1998-02-15

2.  Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha.

Authors:  S Sel; T Ebert; G U Ryffel; T Drewes
Journal:  Cancer Lett       Date:  1996-03-29       Impact factor: 8.679

3.  Multiple post-translational modifications in hepatocyte nuclear factor 4α.

Authors:  Atsushi Yokoyama; Shogo Katsura; Ryo Ito; Waka Hashiba; Hiroki Sekine; Ryoji Fujiki; Shigeaki Kato
Journal:  Biochem Biophys Res Commun       Date:  2011-06-17       Impact factor: 3.575

Review 4.  Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences.

Authors:  G U Ryffel
Journal:  J Mol Endocrinol       Date:  2001-08       Impact factor: 5.098

Review 5.  Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.

Authors:  N L Lazarevich; D A Shavochkina; D I Fleishman; I F Kustova; O V Morozova; E S Chuchuev; Y I Patyutko
Journal:  Exp Oncol       Date:  2010-09

6.  Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.

Authors:  Chuan Yin; Pei-Qin Wang; Wen-Ping Xu; Yuan Yang; Qing Zhang; Bei-Fang Ning; Ping-Ping Zhang; Wei-Ping Zhou; Wei-Fen Xie; Wan-Sheng Chen; Xin Zhang
Journal:  Hepatology       Date:  2013-10-22       Impact factor: 17.425

7.  Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.

Authors:  Natalia L Lazarevich; Oksana A Cheremnova; Ekaterina V Varga; Dmitry A Ovchinnikov; Elena I Kudrjavtseva; Olga V Morozova; Daria I Fleishman; Natalia V Engelhardt; Stephen A Duncan
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

8.  SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.

Authors:  Jen-Chywan Wang; John M Stafford; Daryl K Granner
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

Review 9.  A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis.

Authors:  Vincenzo D'Angiolella; Mine Esencay; Michele Pagano
Journal:  Trends Cell Biol       Date:  2012-11-19       Impact factor: 20.808

10.  Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data.

Authors:  Marc E Lenburg; Louis S Liou; Norman P Gerry; Garrett M Frampton; Herbert T Cohen; Michael F Christman
Journal:  BMC Cancer       Date:  2003-11-27       Impact factor: 4.430

View more
  54 in total

1.  TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation are Attenuated by Combined Disruption of MET and EGFR Signaling.

Authors:  Bharat Bhushan; John W Stoops; Wendy M Mars; Anne Orr; William C Bowen; Shirish Paranjpe; George K Michalopoulos
Journal:  Hepatology       Date:  2018-12-31       Impact factor: 17.425

Review 2.  The role of lineage specifiers in pancreatic ductal adenocarcinoma.

Authors:  Soledad A Camolotto; Veronika K Belova; Eric L Snyder
Journal:  J Gastrointest Oncol       Date:  2018-12

3.  A vascular-liver chip for sensitive detection of nutraceutical metabolites from human pluripotent stem cell derivatives.

Authors:  Fang Yu; Yeek Teck Goh; Huan Li; Narmada Balakrishnan Chakrapani; Ming Ni; Guo Lin Xu; Tseng-Ming Hsieh; Yi-Chin Toh; Christine Cheung; Ciprian Iliescu; Hanry Yu
Journal:  Biomicrofluidics       Date:  2020-05-27       Impact factor: 2.800

4.  Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation.

Authors:  Kelley G Núñez; Janet Gonzalez-Rosario; Paul T Thevenot; Ari J Cohen
Journal:  Ochsner J       Date:  2017

5.  The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.

Authors:  Kevin M Beggs; Steven R McGreal; Alex McCarthy; Sumedha Gunewardena; Jed N Lampe; Christoper Lau; Udayan Apte
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-03       Impact factor: 4.219

Review 6.  Gankyrin as a potential therapeutic target for cancer.

Authors:  Chongchong Wang; Li Cheng
Journal:  Invest New Drugs       Date:  2017-05-19       Impact factor: 3.850

7.  Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.

Authors:  Ben Yi Tew; Christophe Legendre; Mark A Schroeder; Tim Triche; Gerald C Gooden; Yizhou Huang; Loren Butry; Daniel J Ma; Kyle Johnson; Rae Anne Martinez; Mariaelena Pierobon; Emanuel F Petricoin; Joyce O'shaughnessy; Cindy Osborne; Coya Tapia; David N Buckley; Jennifer Glen; Mark Bernstein; Jann N Sarkaria; Steven A Toms; Bodour Salhia
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

8.  Hnf4a Is Required for the Development of Cdh6-Expressing Progenitors into Proximal Tubules in the Mouse Kidney.

Authors:  Sierra S Marable; Eunah Chung; Joo-Seop Park
Journal:  J Am Soc Nephrol       Date:  2020-08-06       Impact factor: 10.121

9.  Long non-coding RNA LINC00858 exerts a tumor-promoting role in colon cancer via HNF4α and WNK2 regulation.

Authors:  Ting Xu; Kun Wu; Lei Zhang; Shutao Zheng; Xiaopeng Wang; Hao Zuo; Xu Wu; Guoquan Tao; Baofei Jiang; Li Zhang
Journal:  Cell Oncol (Dordr)       Date:  2019-12-28       Impact factor: 6.730

10.  Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.

Authors:  Andrea Pellagatti; Richard N Armstrong; Violetta Steeples; Eshita Sharma; Emmanouela Repapi; Shalini Singh; Andrea Sanchi; Aleksandar Radujkovic; Patrick Horn; Hamid Dolatshad; Swagata Roy; John Broxholme; Helen Lockstone; Stephen Taylor; Aristoteles Giagounidis; Paresh Vyas; Anna Schuh; Angela Hamblin; Elli Papaemmanuil; Sally Killick; Luca Malcovati; Marco L Hennrich; Anne-Claude Gavin; Anthony D Ho; Thomas Luft; Eva Hellström-Lindberg; Mario Cazzola; Christopher W J Smith; Stephen Smith; Jacqueline Boultwood
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.